Summary: This study investigates how the neuronal and in ducible nitric oxide synthase (NOS) pathways contribute to the cerebrovascular changes in the early phase of experimental pneumococcal meningitis in rats. Using a closed cranial win dow preparation, the diameters of pial arterioles were measured during 4 hours after intracisternal injection of heat-killed pneu mococci and compared with controls (n = 6). Injection of pneumococci (n = 7) caused a significant increase in pial arteriolar diameter (157 ± 22% after 4 hours; P < 0.05, com pared with 104 ± II % in controls), intracranial pressure, CSF white blood cell counts, and brain water content. Treatment with the neuronal NOS inhibitor 7-nitroindazole (50 mg/kg given intraperitoneally, n = 5) prevented pneumococci induced vasodilation (l07 ± 20% at 4 hours), whereas S methylisothiourea (SMT; 0. I mg/kg given intraperitoneally, Bacterial meningitis in adults still is a serious disease. Mortality rates for pneumococcal meningitis are still as high as 20% to 30% (Berkowitz, 1993; Durand et ai, 1993; Pfister et aI., 1993). Major complications during the course of the disease include brain edema, increased intracranial pressure (lCP) , and cerebrovascular alter ations (e.g., focal cortical hyperperfusion, arterial steno sis and spasms), as well as septic sinus venous throm bosis (Pfister et aI., 1992). Pial arteriolar vasodilation and an increase in cerebral blood flow are found in early stages of experimental bacterial meningitis (Pfister et aI., 1990; Berkowitz et aI., 1993), whereas a reduced cereReceived July 31 , 1996; final revision received February 12, 1997: accepted April 10, 1997.
n = 5), which predominantly inhibits the inducible NOS, did not influence pneumococci-induced vasodilation (154 ± 38% at 4 hours). S-methylisothiourea at a dose of 1.0 mg/kg (n = 5), attenuated the vasodilation (124 ± 18% at 4 hours). However, the increase in mean arterial blood pressure after SMT at 1.0 mg/kg, but not at 0. I mg/kg, suggests that the higher dose of SMT influenced the constitutive NOS activity, causing inhibi tion of the pneumococci-induced vasodilation. Neither SMT (at both doses) nor 7-nitroindazole influenced the increase in brain water content, intracranial pressure, and CSF white blood cell counts in pneumococci-challenged rats. Our study suggests that pial arteriolar vasodilation in the early phase of experimental pneumococcal meningitis is mediated by the neuronal NOS pathway. Key Words: Pneumococcal meningitis-Cranial window-Nitric oxide synthase-Vasodilation-Nitric oxide.
bra1 blood flow may be observed in advanced phases of the disease (Smith et a!., 1982; Tureen et aI., 1990) . Recent experimental studies show that nitric oxide (NO) is involved in the pathophysiologic alterations in bacte rial meningitis (Habert et a!., 1994; Boje, 1995; Buster et aI., 1995; Koedel et aI., 1995) . Nitric oxide is produced from L-arginine by nitric oxide synthases (NOS). Three isoenzymes of NOS have been identified: the constitu tive endothelial isoform (eNOS), the constitutive neuro nal isoform (nNOS), and the inducible isoform (iNOS) (Nathan and Xie, 1994; Schmidt and Walter, 1994; Kro ncke et aI., 1995) . Whereas the constitutive isoforms are calcium/calmodulin-dependent, the activation of the iNOS is ca1cium/calmodulin-independent and requires DNA transcription and protein synthesis after induction by various stimuli, such as lipotechoic acid (Auguet et aI., 1992) , lipopolysaccharide (Geller et aI., 1993; Liu et aI., 1993) , and cytokines, especially tumor necrosis fac tor-a (Colasanti et aI., 1995; Greenberg et aI., 1995) and interleukin-113 (Geller et aI., 1993; Nussler and Billiar, 1993) . Treatment with the nonselective NOS inhibitors N G -nitro-L-arginine and N G -nitro-L-arginine methyl ester significantly modulated the pial arteriolar vasodilation, the increase in regional cerebral blood flow, changes in blood-brain barrier permeability, CSF nitrite levels, brain water content, ICP, and cerebrospinal fluid white blood cell (CSF-WBC) counts in animal models of bac terial meningitis (Haberl et aI., 1994; Buster et aI., 1995; Koedel et aI., 1995) . This study aimed to determine how the nNOS and iNOS contribute to pneumococci-induced arteriolar vasodilation in a rat model of meningitis. Using a closed cranial window preparation, we investigated the efficacy of the selective nNOS inhibitor 7-nitroindazole (7-NI) (Babbedge et aI., 1993; Moore et aI., 1993; Kelly et aI., 1995) gnd S-methylisothiourea (SMT), which is reported to predominantly inhibit iNOS activity (Garvey et aI., 1994; Szab6 et aI., 1994) to influence the early pathophysiologic changes in experimental pneumococcal meningitis.
MATERIALS AND METHODS

Rat model of pneumococcal meningitis
The protocols used in this study were approved by the gov ernment of Upper Bavaria. A well-characterized rat model of pneumococcal meningitis was used in this study, which was previously described in detail (Pfister et aI., 1990) . Briefly, 34 adult male Wistar rats (250 to 350 g) were anesthetized with thiopental (100 mg/kg given intraperitoneally), tracheotomized, and artificially ventilated with a small animal ventilator (model 683, Harvard Apparatus Co., South Natick, MA, U.S.A.). Supplemental anesthetic doses were administered to maintain anesthesia. A catheter was inserted into the left femoral artery for continuous !honitoring of mean arterial blood pressure and for hourly analysis of Pac02, Pa02, and pH with a blood gas analyzer (IL 1304, Instrumentation Laboratory, Kirchheim, Germany) . At the beginning and the end of the experiment, hematocrit was determined. The left femoral vein was cannu lated for fluid substitution. To apply 7-NI, a catheter was in serted into the peritoneum for intraperitoneal injection. The rats were kept at a constant temperature of 37.5° ± 0.5°C using a rectal thermometer-controlled heating pad. A burr hole was made at the occipital bone, and a catheter was inserted into the cisterna magna for continuous ICP monitoring, injection of pneumococci, and determination of CSF-WBC counts before pneumococcal challenge and at the end of the experiment. For data analysis, the increase in ICP compared with the baseline (MCP) was calculated. At the end of the experiment, the brain was removed and the brain water content-a parameter for brain edema formation-was determined as previously de scribed (Koedel et aI., 1995) using the formula (wet weightdry weight)/wet weight x 100 [% J.
Preparation of a closed cranial window
The pial microcirculation was visualized through a closed cranial window prepared as previously described (Morii et aI., 1986; Koedel et aI., 1995) . A rectangular craniotomy (8 x 5 mm) was performed in the mediocaudal portion of the right parietal bone. Bone wax was placed around the bone gap, em bedding the end of two polyethylene tubes subsequently used as an inlet and outlet. The dura was incised and stripped, ex posing the transparent arachnoid and the underlying pial ves sels on the brain surface. The cranial window was closed with a glass coverslip and sealed with dental acrylic (Paladur, Her aeus, Wehrheim, Germany mmol/L of urea, and 25 mEq/L of HC03- (Morii et aI., 1986) , This fluid was equilibrated with 6.6% oxygen, 5.9% carbon dioxide, and the balance of nitrogen, which gave a pH = 7.4 at 37°C, Pial arterioles ranging from 18 to 112 f.Lm (median 47 f.Lm) were observed with a trinocular microscope (Leitz GmbH, Munich, Germany) and recorded by using a low light level video camera (Panasonic WV 1550/G) connected with a video recorder (Panasonic AG 6200-EG) and a video monitor (Barco CD 233, Kortijk, Belgium). Pial arteriolar diameters were mea sured with a image analysis system for a personal computer (Stemmer Elektronik GmbH, Puchheim, Germany). We inves tigated the diameter of pial arterioles at different sites (three per animal) every 30 minutes for a period of 4 hours after intra cisternal injection of pneumococci. Changes of diameter were expressed as percentage from a baseline of 100%. Carbon di oxide reacti vity of pial arterioles was investigated at baseline conditions to eliminate disturbed vasoreactivity caused the sur gical procedure. After hypercapnia, an increase in diameter of more than I % per 1 mm Hg increase in Paco2 was required for inclusion in the study (Tuor and Farrar, 1984) . The pH of the superfusate in the chamber under the cranial window was de termined at the end of the experiment (4 hours after intracis ternal injection) to exclude acidosis as the cause of vasodila tion.
Intracisternal inoculum
Heat-killed (60°C for 4 hours) unencapsulated pneumococci, which stem from an isogenic mutant of the encapsulated strain Streptococcus pneumoniae type 3 (no. 17260), were used for intracisternal challenge (Pfister et aI., 1990; Koedel et aI., 1995) . Intracisternal injection of heat-killed pneumococci in duces meningeal inflammation with changes in regional cere bral blood flow, brain water content, ICP, and CSF-WBC counts similar to those seen after injection of live pneumococci, as previously reported (Koedel et aI., 1995) .
Induction of meningitis
When carbon dioxide reactivity of pial vessels was docu mented, 100 f.LL CSF was removed using the intracisternal catheter. The rats were challenged intracisternally with 100 f.LL of 108 colony forming units per milliliter of heat-killed pneu mococci.
Experimental groups
Seven experimental groups were investigated: Group 1. Six untreated rats were injected intracisternally with phosphate-buffered saline (PBS) (controls).
Group 2. Seven rats were left untreated and injected intra cisternally with pneumococci.
Group 3. Five rats were treated with 50 mg/kg of 7-NI given intraperitoneally (Alexis Corporation, Griinberg, Germany), dissolved in 10 mL/kg of peanut oil (Sigma Chemicals, Dei senhofen, Germany) 15 minutes before and 2 hours after intra cisternal injection of pneumococci. Since 7-NI was reported to produce maximum inhibition of nNOS activity 0.5 hours after intraperitoneal administration, reaching 80% to 85% and de clining to 36% to 54% after 4 hours (MacKenzie et aI., 1994), we administered a second dose 2 hours after pneumococcal challenge to achieve maximum inhibition during the whole time of observation.
Group 4. Three rats were treated with 10 mL/kg of peanut oil 15 minutes before and 2 hours after intracisternal injection of PBS.
Group 5. Three rats were treated with 10 mL/kg of peanut oil 15 minutes before and 2 hours after intracisternal injection of pneumococci.
Group 6. Five rats were treated with 0.1 mg/kg of SMT given intraperitoneally (Alexis Corporation, Grunberg. Ger many, dissolved in 0.9% sodium chloride solution) 15 minutes before intracisternal injection of pneumococci. This dose was previously shown to be effective in inhibiting iNOS activity in mice and rat sepsis models (Szab6 et aI., J 994; Kengatharan et aI., J 995).
Group 7. Five rats were treated with 1.0 mg/kg of SMT given intraperitoneally 15 minutes before intracisternal injec tion of pneumococci.
Statistics
Data on vessel diameter, IlICP, brain water content, CSF-WBC counts, and physiologic parameters for groups 1 and 2 were compared hourly after intracisternal injection of PBS/pneumococci using the unpaired Stu dent's t-test. Data on vessel diameter, IlICP, brain water content, CSF-WBC counts, and physiologic parameters from groups 2 through 7 were compared hourly after intracisternal injection of PBS/pneumococci using one way analysis of variance and Scheffe's test. P values were corrected for repeated measurements using the Bonferroni Holm procedure. Data on increase in mean arterial blood pressure 30 minutes after administration of SMT (both doses) (groups 6 and 7) were compared with group 2 using one-way analysis of variance and Schef fe's test. Data on increase in mean arterial blood pressure 30 minutes after administration of 7-NI (group 3) were compared wit'll group 2 using the unpaired Student's t test. Differences were considered significant at P < 0.05. Data are expressed as means ± standard deviation.
RESULTS
Physiologic variables
Data on Pao2, Paco2, pH, CSF-pH, mean arterial blood pressure, and hematocrit were within normal ranges in all experimental groups (Table 1 ) and were not statistically significant. For mean arterial blood pressure changes caused by the administration of 1.0 mg/kg of SMT (see later).
Documentation of meningeal inflammation
There was a significant increase in CSF-WBC in rats challenged with pneumococci (group 2: 3124 ± 3437) compared with controls (group 1: 1 ± 2; P < 0.05). Treat ment with 7-NI (group 3: 1280 ± 1015; ns) and SMT in both doses (group 6: 5973 ± 4327; group 7: 5081 ± 4390; ns) did not significantly alter CSF-WBC counts com pared with untreated, pneumococci-injected rats (group 2). Treatment with peanut oil (vehicle) per se did not influence the CSF-WBC counts of rats intracisternally injected with PBS and pneumococci (group 4: 0 ± 0; group 5: 3776 ± 2448).
Effect of 7-nitroindazole and S-methylisothiourea on mean arterial blood pressure 7-Nitroindazole and SMT at 0.1 mg/kg had no signifi cant effect on the change in mean arterial blood pressure (3 ± 9 mm Hg and 4 ± 5 mm Hg, respectively, compared with -1 ± 4 mm Hg in untreated rats) 30 minutes after administration. This suggests that there was no signifi cant inhibition of eNOS activity. An increase in mean arterial blood pressure is regarded as an indicator of eNOS inhibition (Szabo et aI., 1994) . S Methylisothiourea at 1.0 mg/kg caused a significant in crease in mean arterial blood pressure by 8 ± 5 mm Hg (compared with rats treated with SMT at 0. 1 mg/kg and untreated rats; P < 0.05) measured 30 minutes after ad ministration, indicating an inhibitory effect on eNOS ac tivity at this dose. n, number of rats investigated; time, time after intracisternal injection; SMT, S-methylisothiourea; 7-NI. 7-nitroindazole; NO , not determined . Values are mean ± SO. There were no significant differences between the experimental groups .
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Effect of 7-nitroindazole and S-methylisothiourea on pneumococci-induced pial arteriolar vasodilation
Intracisternal injection of pneumococci caused a pro gressive dilation of pial arterioles that became statisti cally significant as early as 1 hour after pneumococcal challenge (114 ± 13%; P < 0.05, compared with controls) reaching 157 ± 22% 4 hours after intracisternal injection (compared with 104 ± 11 % in controls; P < 0.05) (Fig.  1) . Treatment with 7-NI significantly inhibited pneumo cocci-induced pial arteriolar vasodilation (107 ± 20% 4 hours after intracisternal challenge; P < 0.05, compared with untreated, pneumococci-injected rats). Intraperito- SMT at 1.0 mg/kg significantly attenuated pneumococci-induced vasodilation. Data were compared every hour. Data are mean ± standard deviation. * P < 0.05 compared with pneumococci injected, untreated rats. xP < 0.05 compared with pneumococci injected rats treated with 7-NI. +P < 0.05 compared with pneu mococci-injected rats treated with SMT at 0.1 mg/kg. neal injection of 10 mLlkg peanut oil (vehicle) had no significant effect on PBS-injected rats (104 ± 4% com pared with 104 ± 11 % in controls without vehicle 4 hours after intracisternal challenge) and pneumococci-injected rats (160 ± 29% compared with 157 ± 22% in pneumo cocci-injected rats without vehicle 4 hours after intracis ternal challenge), Treatment with SMT at 0, I mg/kg did not significantly alter pneumococci-induced vasodilation (154 ± 38% at 4 hours after pneumococcal challenge; ns, compared with 157 ± 22% after 4 hours in pneumococci injected, untreated rats; P < 0,05, compared with 107 ± 20% after 4 hours in pneumococci-injected rats, treated with 7-NI). Treatment with SMT at 1.0 mg/kg signifi cantly attenuated pneumococci-induced vasodilation (125 ± 18% 4 hours after intracisternal injection; P < 0.05, compared with untreated, pneumococci-injected rats as well as to rats treated with SMT at 0.1 mg/kg).
Effect of 7-nitroindazole and S-methylisothiourea on brain water content and intracranial pressure
Intracisternal injection of pneumococci caused a sig nificant increase in ICP (MCP was 6.6 ± 2,5 mm Hg at 4 hours after pneumococcal challenge) (Fig. 2 ) and brain water content (79,47 ± 0,46%), compared with controls (LlICP was -0.2 ± 0,4 mm Hg at 4 hours after injection of PBS, brain water content was 78,92 ± 0.27%; P < 0.05), Treatment with 7-NI and SMT (0. 1 mg/kg and 1.0 mg/kg, respectively) had no significant inhibitory effect on LllCP (8.0 ± 3.9 mm Hg, 8.8 ± 6.8 mm Hg, and 8,4 ± 1,9 mm Hg 4 hours after intracisternal injection, respec tively) (Fig, 2 ) and brain water content (79.73 ± 0.35%, 79,44 ± 0.23%, and 79.88 ± 0.51 %, respectively), com pared with untreated, pneumococci-injected rats. Treat ment with peanut oil (vehicle) per se did not influence LlICP and brain water content of rats intracisternally in jected with PBS and pneumococci (0,3 ± 0.6 mm Hg and 7.2 ± 3.8 mm Hg after 4 hours, 78.81 ± 0.32% and 79.65 ± 0.36%, respectively),
DISCUSSION
There is increasing evidence that NO acts as a media tor of int1ammation during bacterial meningitis, since the NOS inhibitors N G -nitro-L-arginine and N G -nitro-L arginine methyl ester attenuated the increases in pial ar teriolar vessel diameter, regional cerebral blood flow, brain water content, CSF-WBC counts, and CSF-nitrite concentrations, as well as changes in blood-brain barrier permeability in animal models of bacterial meningitis (Haberl et aI., 1994; Buster et aI., 1995; Koedel et aI., 1995) . Moreover, elevated levels of nitrate and nitrite (breakdown products of NO), which are regarded as markers of increased NO production, are found in CSF of patients with bacterial meningitis (Milstien et aI., 1994; Visser et at, 1994) , The major finding of this study is that 7-NI, a selective inhibitor of the nNOS (Babbedge et Data were compared every hour. Data are means ± standard deviation. 'p < 0.05 compared with controls.
aI., 1993; Moore et aI., 1993) , prevented pneumococci induced pial arteriolar vasodilation in the early phase of experimental meningitis. 7-Nitroindazole is a potent and competitive inhibitor of rat brain NOS in vitro and in vivo (Babbedge et aI., 1993; Moore et aI., 1993; Bland-Ward and Moore, 1995) . 7-Nitroindazole does not influence the endothe lium-dependent vasodilation of acetylcholine (Yoshida et aI., 1994) , nor does it cause an increase in arterial blood pressure in vivo (Moore et aI., 1993) , indicating that eNOS function is preserved. In agreement with these observations, we did not find an increase in mean arterial blood pressure in the current study 30 minutes after ad ministration of 7-NL The nNOS is present in neurons (Bredt and Snyder, 1994) and glial cells (Kugler and Drenckhahn, 1996) . Moreover, it seems that nerve fibers that innervate large cerebral arteries and pial vessels con tain nNOS (Bredt et aI., 1990) . There are studies indi cating that the nNOS is at least partly responsible for the control of cerebral blood flow under normal (Kelly et aI., 1995; Iadecola et aI., 1996) and pathophysiologic condi tions, such as hypercapnia (Wang et aI., 1995) and hem orrhagic hypotension (Kovach et aI., 1994) . In addition, inhibition of nNOS by 7-NI was shown to reduce the infarction size in a model of focal cerebral ischemia (Y oshida et aI., 1994) , which suggests that brain-derived NO plays an important role in neurotoxicity. The nNOS pathway can be activated by various substances, includ ing glutamate (Wood and Garthwaite, 1994) , vasoactive intestinal polypeptide (Kummer et aI., 1992) , and sub stance P (Kajekar et aI., 1995) . In a rabbit model of pneumococcal meningitis, elevated concentrations of glutamate were detected in the CSF 22 hours after infec tion (Guerra-Romero et aI., 1993) , indicating an in creased release of glutamate during the course of the intlammation. Substance P, which is released by perivas cular nerves originating from the trigeminal ganglion (Edvinsson, 1991) , induces dilation of pial arterioles (Edvinsson et aI., 1981) . A previous study using the same rat model as in the current study showed that the sub stance P antagonist spantide was able to prevent pial arteriolar vasodilation in the early phase of experimental pneumococcal meningitis (Pfister et aI., 1995) .
To investigate the contribution of the iNOS pathway to the early inflammatory process of experimental men ingitis, we tested the possible effect of SMT, a potent NOS inhibitor, which mainly inhibits iNOS (Szabo et aI., 1994; Southan et aI., 1995) . Intraperitoneal administra tion of 0.1 mg/kg of SMT was previously shown to im prove the survival rate in a mice model of septic shock (Szabo et aI., 1994) . In a rat sepsis model, SMT at a dose of 0.01 to 3 mg/kg restored the lipopolysaccharide induced decrease in mean arterial pressure to preshock values (Kengatharan et aI., 1995) . In the current study, 0.1 mg/kg of SMT did not alter pneumococci-induced pial arterial vasodilation. The higher dose of SMT at tenuated pneumococci-induced vasodilation; however, this dose caused an increase in mean arterial blood pres sure, suggesting that SMT at 1.0 mg/kg additionally in hibits the constitutive NOS pathway. Both doses of SMT did not modulate changes in brain water content, ICP, and CSF pleocytosis after pneumococcal challenge. Therefore, our data suggest that NO produced by iNOS may not be involved in the early phase of experimental pneumococcal meningitis.
Further arguments for this are the observations that (l) mRNA of iNOS was detected in meninges of rat brains during systemic inflammation 6 hours, but not 2 hours after systemic lipopolysaccharide administration (Wong et aI., 1996) ; (2) iNOS activity in homogenates of dif ferent tissues was found 3 hours, but not 1 hour after systemic administration of lipopolysaccharide in rats (Szab6 et aI., 1993); and (3) elevated CSF nitrite con centrations were found 4 hours, but not 2 hours after intracisternal challenge in a rat model of meningitis (Buster et aI., 1995) . All of these observations suggest that the iNOS pathway is not the major source of NO during the first hours of experimental meningitis.
We recently found that the un selective NOS inhibitors N G -nitro-L-arginine and N G -nitro-L-arginine methyl ester significantly reduced the increase in brain water content, ICP, CSF-W B C counts, and CSF nitrite concentrations in the same rat model of pneumococc, al meningitis (Haberl et aI., 1994; Koede1 et aI., 1995) . In this study, both SMT (at both doses) and 7-NI were ineffective and did not influence these parameters. Thus, taken together, these findings argue for the involvement of eNOS activ ity rather than nNOS and iNOS activity in alterations of brain water content, ICP, and CSF-WBC counts in the early phase of pneumococcal meningitis.
